Skip to content

BAXJECT II 5500460Recalls & reported problems

Shire Human Genetic Therapies, Inc. · Needleless Transfer Device · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00642621073447), received between Jun 9, 2023 and Jun 9, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Contamination” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Contamination1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 9, 2023Contamination

    ADDITIONAL INFORMATION RECEIVED FROM REPORTER ON 01-NOV-2023, FOR MW5118298. PATIENT CONTACTED AN EMPLOYEE OF (B)(6) PHARMACY, INC. AND SENT PHOTOS OF THE MEDICATION SYRINGE WHICH CONTAINED SHARDS OF PLASTIC IN THE MEDICATION SOLUTION. THIS WAS ALREADY REPORTED AND RESULTED IN A VOLUNTARY RECALL OF THE BAXJECT II DEVICE. THIS WAS REPORTED AFTER THE VOLUNTARY RECALL ON 08/28/2023.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17106663 ↗

Other Set, I.V. Fluid Transfer devices

All Set, I.V. Fluid Transfer devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page